Medication info
Neocande Tablet 32 mg (Candesartan Cilexetil)

Neocande Tablet 32 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›32mg / 1 tablet
Manufacturer / importer
Gc Pharma Co., Ltd.
Appearance
Pink, round, biconvex tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202403022 · Approved 2024.12.19 · Insurance code 643606810

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of initiating treatment. 2) Elderly patients: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, depending on the patient's tolerability. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No dose adjustment is necessary.
Child dose
The safety and efficacy in adolescents and children aged 18 years and younger have not been established. The safety and efficacy in adolescents and children aged 18 years and younger have not been established.

Ingredients

Manufacturer
Gc Pharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • decreased left ventricular ejection fraction
View approved original text

This medication is used to treat essential hypertension and heart failure. It is particularly effective for heart failure patients with impaired left ventricular systolic function who require additional treatment beyond ACE inhibitors or cannot tolerate ACE inhibitors. It helps improve the symptoms of heart failure, reduce the burden on the heart, and stabilize blood pressure. Therefore, it is used for the treatment of essential hypertension and various heart failure patients.

How to take

Adult dose

Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of initiating treatment. 2) Elderly patients: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, depending on the patient's tolerability. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No dose adjustment is necessary.

Child dose

The safety and efficacy in adolescents and children aged 18 years and younger have not been established. The safety and efficacy in adolescents and children aged 18 years and younger have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken by pregnant women, so it must be discontinued immediately upon confirmation of pregnancy. Persons with allergies to this medication or its components, those who are pregnant or breastfeeding, individuals with severe liver dysfunction or biliary obstruction, and those with specific genetic disorders should not take this medication. Elderly patients, individuals with hyperkalemia, those with liver dysfunction, patients with heart valve disease or cerebrovascular disorders, and patients with decreased kidney function should use this medication with caution and require regular monitoring. As this medication lowers blood pressure, symptoms of hypotension may occur, and dizziness or fatigue may arise, so caution is advised while driving or operating machinery. While taking this medication, serum potassium and kidney function should be monitored periodically to ensure no abnormalities arise, especially when used with other antihypertensive drugs or potassium-sparing diuretics. This medication may occasionally cause side effects such as skin rash, itching, difficulty breathing, muscle pain, gastrointestinal disturbances, etc., so if any abnormal symptoms occur, consult a healthcare professional immediately. Women planning pregnancy or who may become pregnant should discuss this medication with their physician before use, and breastfeeding women should also avoid taking this medication. Overdosage may result in hypotension, dizziness, rapid heartbeat, etc., and prompt medical attention should be sought. The safety and efficacy in children and adolescents have not been sufficiently established, so it is advisable not to use this age group. This medication should be stored out of reach of children and should be kept in its original container to maintain its quality.

Side effects

  • Dizziness
  • back pain
  • respiratory infection
  • weakness
  • fever
  • altered sensation
  • dyspepsia
  • gastroenteritis
  • tachycardia
  • palpitations
Show 60 more
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • renal impairment
  • increased creatinine
  • increased urea
  • increased potassium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • headache
  • cough
  • intestinal vascular edema
  • nausea
  • diarrhea
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • hives
  • pruritus
  • angioedema
  • rhabdomyolysis
  • arthralgia
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • syncope
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • decreased libido
  • forgetfulness
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste disorder
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. Additionally, it is important to maintain storage at room temperature between 1°C and 30°C to preserve its efficacy.

Appearance and packaging

Appearance

Pink, round, biconvex tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.